No licensed prescriber will write for it

Absolute Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Previous serious hypersensitivity to semaglutide or formulation components Pregnancy (discontinue at least 2 months before planned conception) Breastfeeding (insufficient data on excretion in human milk) Relative Contraindications (Use with Caution and Medical Supervision): History of pancreatitis (potential risk factor) Severe gastrointestinal disease including gastroparesis Diabetic retinopathy (requires ophthalmologic monitoring) Severe kidney disease (limited data in advanced renal impairment) History of suicidal ideation or severe depression (monitor mental health) Gallbladder disease or history of cholecystitis Age under 18 (pediatric safety not established for most formulations) How Semaglutide Side Effects Compare to Similar Peptides Understanding how semaglutides side effect profile compares to other weight management and metabolic peptides helps inform treatment selection

Mood stabilizers are essential medications in managing mental health conditions like bipolar disorder, depression, and anxiety
GHK-Cu inhibits its activation and thereby reduces the production of pro-inflammatory cytokines, chemokines, and adhesion molecules
Avoid B12 unless tested and cleared The risk of clot formation increases 4
Cagrilintide is an investigational compound that is not approved by the FDA, the EMA, or any other regulatory authority for human therapeutic use as a monotherapy